Total Payments
$8,144
2024 Payments
$1,143
Companies
29
Transactions
275
Medicare Patients
16,891
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$6,523 (80.1%)
Travel$890.20 (10.9%)
Consulting$700.00 (8.6%)
Research$16.87 (0.2%)
Education$13.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,523 | 267 | 80.1% |
| Travel and Lodging | $890.20 | 5 | 10.9% |
| Consulting Fee | $700.00 | 1 | 8.6% |
| Unspecified | $16.87 | 1 | 0.2% |
| Education | $13.89 | 1 | 0.2% |
Payments by Type
General
$8,127
274 transactions
Research
$16.87
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Medical LLC | $1,138 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,116 | 9 | $0 (2023) |
| Abbott Laboratories | $985.22 | 8 | $0 (2022) |
| Amgen Inc. | $637.38 | 23 | $0 (2024) |
| Penumbra, Inc. | $530.80 | 12 | $0 (2023) |
| AngioDynamics, Inc. | $530.60 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $378.54 | 17 | $0 (2024) |
| Medtronic, Inc. | $374.89 | 8 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $365.49 | 26 | $0 (2024) |
| Cardiovascular Systems Inc. | $330.08 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,143 | 48 | Medtronic, Inc. ($309.61) |
| 2023 | $657.96 | 39 | AngioDynamics, Inc. ($228.03) |
| 2022 | $970.32 | 57 | AngioDynamics, Inc. ($266.61) |
| 2021 | $442.88 | 31 | Bard Peripheral Vascular, Inc. ($219.59) |
| 2020 | $1,410 | 25 | Abbott Laboratories ($715.26) |
| 2019 | $2,116 | 49 | GlaxoSmithKline, LLC. ($1,013) |
| 2018 | $967.22 | 21 | Cook Medical LLC ($346.18) |
| 2017 | $436.24 | 5 | AstraZeneca Pharmaceuticals LP ($217.03) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Bard Peripheral Vascular, Inc. | RotarexS 6 F x 135 cm (Device) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Vascular/Oncology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.95 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: Endovascular | ||||||
| 09/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Not Applicable | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.58 | General |
| Category: Cardiovascular | ||||||
| 09/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: PAD | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.76 | General |
| Category: Cardiovascular | ||||||
| 06/26/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $18.15 | General |
| 06/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 59 | 4,163 | 5,957 | $1.5M | $540,157 |
| 2022 | 56 | 3,851 | 6,416 | $1.5M | $537,431 |
| 2021 | 57 | 4,392 | 6,724 | $1.1M | $428,439 |
| 2020 | 54 | 4,485 | 7,611 | $1.3M | $472,768 |
Total Patients
16,891
Total Services
26,708
Medicare Billing
$2.0M
Procedure Codes
253
All Medicare Procedures & Services
253 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 83 | 83 | $245,182 | $95,432 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 688 | 814 | $175,880 | $69,342 | 39.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 97 | 194 | $154,812 | $60,068 | 38.8% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 15 | 15 | $80,130 | $31,411 | 39.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 213 | 216 | $89,424 | $29,902 | 33.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 143 | 572 | $64,749 | $24,807 | 38.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 118 | 123 | $63,468 | $21,667 | 34.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 66 | 66 | $63,492 | $20,227 | 31.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 81 | 82 | $55,902 | $17,138 | 30.7% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 15 | 23 | $61,617 | $16,678 | 27.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 29 | 38 | $49,020 | $16,624 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 120 | $49,800 | $16,466 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 102 | $29,886 | $12,828 | 42.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 66 | 132 | $31,152 | $11,283 | 36.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 767 | 919 | $31,246 | $8,998 | 28.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 172 | 173 | $25,777 | $8,963 | 34.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 169 | 169 | $23,998 | $8,545 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $20,708 | $7,534 | 36.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 77 | $16,401 | $7,252 | 44.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 86 | $12,814 | $5,321 | 41.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 54 | 90 | $10,530 | $4,959 | 47.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 64 | 67 | $10,318 | $4,264 | 41.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 64 | 183 | $11,529 | $3,659 | 31.7% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $11,696 | $3,555 | 30.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 73 | $7,738 | $2,708 | 35.0% |
About Dr. Christopher Estel, M.D
Dr. Christopher Estel, M.D is a Interventional Cardiology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1992016703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Estel, M.D has received a total of $8,144 in payments from pharmaceutical and medical device companies, with $1,143 received in 2024. These payments were reported across 275 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,523).
As a Medicare-enrolled provider, Estel has provided services to 16,891 Medicare beneficiaries, totaling 26,708 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 253 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Internal Medicine, Cardiovascular Disease
- Location Gainesville, FL
- Active Since 06/25/2010
- Last Updated 07/03/2018
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1992016703
Products in Payments
- Omnilink Elite vascular stent system (Device) $700.00
- AURYON LASER SYSTEM 100-120 VAC (Device) $524.79
- Repatha (Biological) $485.75
- BRILINTA (Drug) $287.71
- Indigo (Device) $263.34
- ELIQUIS (Drug) $245.23
- ENTRESTO (Drug) $233.61
- 3F (Device) $221.28
- Penumbra System (Device) $214.44
- LUTONIX (Device) $200.10
- FFRANGIO (Device) $175.54
- Peripheral Orbital Atherectomy System (Device) $166.92
- ONYX FRONTIER (Device) $164.75
- Corlanor (Drug) $151.63
- LEQVIO (Drug) $144.93
- COOK MEDICAL ZILVER PTX (Device) $133.37
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $129.14
- Coronary Orbital Atherectomy System (Device) $126.21
- Cook Medical Peripheral Intervention (Device) $125.82
- COOK MEDICAL FILTERS (Device) $114.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Gainesville
Dr. Arthur Lee, Md, MD
Interventional Cardiology — Payments: $2.1M
Interventional Cardiology $2.1M
Stephane Rinfret
Interventional Cardiology — Payments: $69,149
Interventional Cardiology $69,149
Dr. Christopher Caputo, Do, DO
Interventional Cardiology — Payments: $67,022
Interventional Cardiology $67,022
Zachary George, M.d, M.D
Interventional Cardiology — Payments: $60,629
Interventional Cardiology $60,629
Dr. Habib Samady, Md, MD
Interventional Cardiology — Payments: $43,588
Interventional Cardiology $43,588
Dr. Jeet Mehta, M.d, M.D
Interventional Cardiology — Payments: $25,361
Interventional Cardiology $25,361